Literature DB >> 24944549

Modern therapeutic concepts of early breast cancer.

Michael Gnant1.   

Abstract

Entities:  

Year:  2014        PMID： 24944549      PMCID： PMC4038315          DOI： 10.1159/000362528

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  12 in total

1.  Fighting overtreatment in adjuvant breast cancer therapy.

Authors:  Michael Gnant; Guenther G Steger
Journal:  Lancet       Date:  2009-12-10       Impact factor: 79.321

2.  I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894.

Authors:  W S Halsted
Journal:  Ann Surg       Date:  1894-11       Impact factor: 12.969

3.  Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer. The International Breast Cancer Study Group.

Authors:  R D Gelber; A Goldhirsch; F Cavalli
Journal:  Ann Intern Med       Date:  1991-04-15       Impact factor: 25.391

4.  Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.

Authors:  Richard Pötter; Michael Gnant; Werner Kwasny; Christoph Tausch; Leonore Handl-Zeller; Brigitte Pakisch; Susanne Taucher; Josef Hammer; Gero Luschin-Ebengreuth; Marianne Schmid; Felix Sedlmayer; Michael Stierer; Georg Reiner; Karin Kapp; Friedrich Hofbauer; Andrea Rottenfusser; Sabine Pöstlberger; Karin Haider; Wolfgang Draxler; Raimund Jakesz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-23       Impact factor: 7.038

5.  Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.

Authors:  M Gnant; M Filipits; R Greil; H Stoeger; M Rudas; Z Bago-Horvath; B Mlineritsch; W Kwasny; M Knauer; C Singer; R Jakesz; P Dubsky; F Fitzal; R Bartsch; G Steger; M Balic; S Ressler; J W Cowens; J Storhoff; S Ferree; C Schaper; S Liu; C Fesl; T O Nielsen
Journal:  Ann Oncol       Date:  2013-12-16       Impact factor: 32.976

Review 6.  Late recurrences in early breast cancer: for whom and how long is endocrine therapy beneficial?

Authors:  Michael Knauer; Martin Filipits; Peter Dubsky
Journal:  Breast Care (Basel)       Date:  2014-05       Impact factor: 2.860

Review 7.  Local treatment of the axilla in early breast cancer: concepts from the national surgical adjuvant breast and bowel project B-04 to the planned intergroup sentinel mamma trial.

Authors:  Toralf Reimer; Steffi Hartmann; Angrit Stachs; Bernd Gerber
Journal:  Breast Care (Basel)       Date:  2014-05       Impact factor: 2.860

8.  The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients.

Authors:  P Dubsky; J C Brase; R Jakesz; M Rudas; C F Singer; R Greil; O Dietze; I Luisser; E Klug; R Sedivy; M Bachner; D Mayr; M Schmidt; M C Gehrmann; C Petry; K E Weber; K Fisch; R Kronenwett; M Gnant; M Filipits
Journal:  Br J Cancer       Date:  2013-10-24       Impact factor: 7.640

9.  Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Authors:  Christina Davies; Hongchao Pan; Jon Godwin; Richard Gray; Rodrigo Arriagada; Vinod Raina; Mirta Abraham; Victor Hugo Medeiros Alencar; Atef Badran; Xavier Bonfill; Joan Bradbury; Michael Clarke; Rory Collins; Susan R Davis; Antonella Delmestri; John F Forbes; Peiman Haddad; Ming-Feng Hou; Moshe Inbar; Hussein Khaled; Joanna Kielanowska; Wing-Hong Kwan; Beela S Mathew; Indraneel Mittra; Bettina Müller; Antonio Nicolucci; Octavio Peralta; Fany Pernas; Lubos Petruzelka; Tadeusz Pienkowski; Ramachandran Radhika; Balakrishnan Rajan; Maryna T Rubach; Sera Tort; Gerard Urrútia; Miriam Valentini; Yaochen Wang; Richard Peto
Journal:  Lancet       Date:  2013-03-09       Impact factor: 79.321

10.  Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.

Authors:  A Goldhirsch; E P Winer; A S Coates; R D Gelber; M Piccart-Gebhart; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2013-08-04       Impact factor: 32.976
View more
  1 in total

Review 1.  St. Gallen/Vienna 2015: A Brief Summary of the Consensus Discussion.

Authors:  Michael Gnant; Christoph Thomssen; Nadia Harbeck
Journal:  Breast Care (Basel)       Date:  2015-04       Impact factor: 2.860
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.